Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 15/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4336294 | 1.00 | AAK1 (0.37) | AAK1S1PR1TRPV1TP53SMN1; SMN2 | |
| SCHEMBL3303016 | 0.88 | IDO1 (0.39) | AAK1S1PR1TP53SMN1; SMN2IDO1 | |
| SCHEMBL3303023 | 0.88 | IDO1 (0.39) | AAK1S1PR1TP53SMN1; SMN2IDO1 | |
| SCHEMBL4416683 | 0.88 | S1PR1 (0.36) | AAK1S1PR1TRPV1 | |
| SCHEMBL4416679 | 0.88 | S1PR1 (0.36) | AAK1S1PR1TRPV1 | |
| SCHEMBL3299918 | 0.87 | S1PR1 (0.37) | AAK1S1PR1TRPV1IDO1 | |
| SCHEMBL3302985 | 0.87 | S1PR1 (0.37) | AAK1S1PR1TRPV1IDO1 | |
| Hydrochloric Acid SCHEMBL3304662 | 0.86 | S1PR1 (0.37) | AAK1S1PR1TRPV1IDO1 | |
| SCHEMBL3309505 | 0.86 | S1PR1 (0.39) | AAK1S1PR1TP53SMN1; SMN2IDO1 | |
| SCHEMBL3309512 | 0.86 | S1PR1 (0.39) | AAK1S1PR1TP53SMN1; SMN2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2058317-B1 | AMINOPHOSPHORIC ACID ESTER DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING THE SAME AS ACTIVE INGREDIENT | KYORIN SEIYAKU KK (JP) | 2013-10-16 | — | — | EP | disclosed |
| US-8232319-B2 | Amino phosphate derivative and S1P receptor modulator having same as an active ingredient | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2012-07-31 | — | — | US | disclosed |
| US-20090325907-A1 | AMINO PHOSPHATE DERIVATIVE AND S1P RECEPTOR MODULATOR HAVING SAME AS AN ACTIVE INGREDIENT | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325907-A1 | AMINO PHOSPHATE DERIVATIVE AND S1P RECEPTOR MODULATOR HAVING SAME AS AN ACTIVE INGREDIENT | S1PR1, S1PR2, S1PR5 | AAK1 427/4885S1PR1 1/4885TRPV1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.